Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer

Published:2021-03 Issue: Volume:20 Page:59-70
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Yang Dong,Chen Tao,Zhan Ming,Xu Sunwang,Yin Xiangfan,Liu Qin,Chen Wei,Zhang Yunhe,Liu Dejun,Yan Jinchun,Huang Qihong,Wang Jian

Funder

China Scholarship Council

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference47 articles.

1. Gallbladder Cancer in the 21st Century;Kanthan;J. Oncol.,2015

2. Gallbladder cancer;Rakić;Hepatobiliary Surg. Nutr.,2014

3. Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree;Gelibter;Cancer,2005

4. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma;Thongprasert;Ann. Oncol.,2005

5. Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study;Kim;BMC Cancer,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer metastases: Tailoring the targets;Heliyon;2024-08

2. Nutrient-epigenome interactions: Implications for personalized nutrition against aging-associated diseases;The Journal of Nutritional Biochemistry;2024-05

3. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway;The Journal of Pathology;2023-06-22

4. Identification of therapeutic targets of gallbladder cancer using multi-omics approach;BRIEF FUNCT GENOMICS;2023

5. Targeted Therapies in Gallbladder Cancer: Current Status and Future Perspectives;Gallbladder Cancer;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3